Breaking News Instant updates and real-time market news.

CYBR

CyberArk

$40.20

-0.51 (-1.25%)

16:07
08/08/17
08/08
16:07
08/08/17
16:07

CyberArk reports Q2 adjusted EPS 21c, consensus 19c

Reports Q2 revenue $57.5M, consensus $57.18M. "While our results in the second quarter were primarily impacted by certain deals in EMEA that did not close by June 30, we continued to see strong demand for our solutions across on premises, cloud and hybrid environments," said Udi Mokady, CyberArk Chairman and CEO. "Our global leadership position in the market, strong demand for our solutions and recent organizational changes position us well to deliver long term growth and capitalize on the tremendous opportunity for privileged account security."

  • 08

    Aug

  • 08

    Aug

  • 19

    Sep

CYBR CyberArk
$40.20

-0.51 (-1.25%)

07/14/17
07/14/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Snap (SNAP) downgraded to Market Perform from Outperform at Cowen with analyst John Blackledge lowering his 2017 and longer-term advertising revenue estimates for Snap to reflect a more competitive environment within Digital advertising. He also believes contribution from the company's new advertising monetization products like Direct Response and Self Serve are not likely to be meaningful in the near term. 2. CyberArk (CYBR) was downgraded to Equal Weight from Overweight at Stephens, to Hold from Buy at Deutsche Bank, and to Neutral from Overweight at JPMorgan. 3. At Home Group (HOME) downgraded to Neutral from Buy at Goldman Sachs with analyst Matthew Fassler citing valuation with the shares up 82% since his upgrade to Buy on November 30, 2016. 4. A10 Networks (ATEN) downgraded to Sector Weight from Overweight at KeyBanc with analyst Alex Kurtz citing "substantially" lower projected growth rates following the company's weaker than expected preliminary second quarter results. 5. Himax (HIMX) downgraded to Underperform from Perform at Oppenheimer with analyst Andrew Uerkwitz saying lowered smartphone expectations in China for 2017 will weigh on the company's near-term orders. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/14/17
NEED
07/14/17
NO CHANGE
Target $55
NEED
Buy
Needham remains a buyer of CyberArk on pre-announcement weakness
Needham analyst Alex Henderson said CyberArk shares are "likely to be in the penalty box" after the company's negative Q2 pre-announcement, though he still strongly believes in the need for Privilege Access Management and thinks GDPR will revitalize growth at the company. Henderson expects valuation to be punished cut his price target on the stock to $55 from $62, though he remains a buyer on weakness and keeps a Buy rating on CyberArk shares.
07/14/17
JMPS
07/14/17
NO CHANGE
JMPS
CyberArk growth will rebound, says JMP Securities
After CyberArk reported weaker than expected results, JMP Securities analyst Erik Suppiger says that the company's European market is "volatile," possibly due to upcoming GDPR regulations or the recent wave of ransomware attacks." The analyst says that "the company's endpoint solution for least privilege management performed well," and he expects its growth to rise "comfortably above 20%." He cut his price target on the shares to $53 from $62 but keeps an Outperform rating on the stock.
07/14/17
SPHN
07/14/17
DOWNGRADE
SPHN
Equal Weight
CyberArk downgraded to Equal Weight from Overweight at Stephens

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
09/24/18
09/24
15:16
09/24/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$95.09

-0.76 (-0.79%)

15:10
09/24/18
09/24
15:10
09/24/18
15:10
Periodicals
Walmart requires lettuce, spinach suppliers to join blockchain, WSJ reports »

In a letter to suppliers,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 15

    Nov

  • 03

    Mar

WFC

Wells Fargo

$54.35

-0.6 (-1.09%)

15:10
09/24/18
09/24
15:10
09/24/18
15:10
Options
Wells Fargo with a notable option spread as shares slip »

Wells Fargo with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Oct

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

BSX

Boston Scientific

$38.37

0.61 (1.62%)

15:05
09/24/18
09/24
15:05
09/24/18
15:05
Options
Boston Scientific call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 09

    Oct

SWCH

Switch

$10.83

-0.23 (-2.08%)

, INTC

Intel

$46.92

0.28 (0.60%)

15:04
09/24/18
09/24
15:04
09/24/18
15:04
Hot Stocks
Intel Capital sells about 1.728M shares of Switch »

According to a regulatory…

SWCH

Switch

$10.83

-0.23 (-2.08%)

INTC

Intel

$46.92

0.28 (0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 22

    Oct

MTNB

Matinas BioPharma

$0.55

0.1392 (33.98%)

, AMRN

Amarin

$11.62

8.62 (287.33%)

15:03
09/24/18
09/24
15:03
09/24/18
15:03
Recommendations
Matinas BioPharma, Amarin analyst commentary  »

Amarin's Vascepa…

MTNB

Matinas BioPharma

$0.55

0.1392 (33.98%)

AMRN

Amarin

$11.62

8.62 (287.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

15:00
09/24/18
09/24
15:00
09/24/18
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

KOS

Kosmos

$9.45

-0.06 (-0.63%)

14:58
09/24/18
09/24
14:58
09/24/18
14:58
Hot Stocks
Breaking Hot Stocks news story on Kosmos »

First Reserve GP XIII…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$10.76

-0.3 (-2.71%)

14:58
09/24/18
09/24
14:58
09/24/18
14:58
Conference/Events
Switch management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

CGC

Canopy Growth

$52.68

2.92 (5.87%)

, CVSI

CV Sciences

$0.00

(0.00%)

14:55
09/24/18
09/24
14:55
09/24/18
14:55
Hot Stocks
NY Governor signs bill adding pain management as condition for medical marijuana »

New York Governor Andrew…

CGC

Canopy Growth

$52.68

2.92 (5.87%)

CVSI

CV Sciences

$0.00

(0.00%)

ACBFF

Aurora Cannabis

$0.00

(0.00%)

CRON

Cronos Group

$11.80

-0.71 (-5.68%)

TLRY

Tilray

$105.00

-18.155 (-14.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

SBUX

Starbucks

$56.88

-0.52 (-0.91%)

14:50
09/24/18
09/24
14:50
09/24/18
14:50
Periodicals
Starbucks plans 'significant changes' to company structure, Bloomberg says »

Starbucks'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

RRGB

Red Robin

$38.65

-0.55 (-1.40%)

14:50
09/24/18
09/24
14:50
09/24/18
14:50
Conference/Events
Red Robin management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ASNA

Ascena Retail

$3.94

-0.29 (-6.86%)

14:49
09/24/18
09/24
14:49
09/24/18
14:49
Options
Ascena Retail options imply 24.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

AMRN

Amarin

$11.13

8.13 (271.00%)

, SNY

Sanofi

$43.33

-0.28 (-0.64%)

14:48
09/24/18
09/24
14:48
09/24/18
14:48
Hot Stocks
Amarin CEO says Vascepa 'more analogous' to statins than PCSK9 inhibitors »

Amarin CEO John Thero…

AMRN

Amarin

$11.13

8.13 (271.00%)

SNY

Sanofi

$43.33

-0.28 (-0.64%)

REGN

Regeneron

$388.88

-1.67 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 20

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

TRXC

TransEnterix

$6.70

0.27 (4.20%)

14:45
09/24/18
09/24
14:45
09/24/18
14:45
Options
TransEnterix call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 27

    Nov

SPPI

Spectrum

$17.18

-4.19 (-19.61%)

14:44
09/24/18
09/24
14:44
09/24/18
14:44
Hot Stocks
Spectrum drops over 20% after releasing poziotinib data from Phase 2 study »

Shares of Spectrum are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

JNJ

Johnson & Johnson

$140.67

-2.18 (-1.53%)

14:43
09/24/18
09/24
14:43
09/24/18
14:43
Periodicals
J&J talc cancer case in California ends in mistrial, Bloomberg reports »

Johnson &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

VSTM

Verastem

$8.98

0.31 (3.58%)

14:39
09/24/18
09/24
14:39
09/24/18
14:39
Hot Stocks
Verastem's Duvelisib approved by FDA »

Duvelisib capsules for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

VSTM

Verastem

$8.98

0.31 (3.58%)

14:38
09/24/18
09/24
14:38
09/24/18
14:38
Hot Stocks
Breaking Hot Stocks news story on Verastem »

Verastem trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

P

Pandora

$9.07

-0.01 (-0.11%)

14:30
09/24/18
09/24
14:30
09/24/18
14:30
Options
Heavy trading in Pandora Monday »

Heavy trading in Pandora…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

GOOG

Alphabet

$1,176.08

9.87 (0.85%)

, GOOGL

Alphabet Class A

$1,183.18

10.96 (0.93%)

14:28
09/24/18
09/24
14:28
09/24/18
14:28
Periodicals
Google to bring Google Lens to Image search results, Engadget says »

According to Engadget,…

GOOG

Alphabet

$1,176.08

9.87 (0.85%)

GOOGL

Alphabet Class A

$1,183.18

10.96 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

VIAB

Viacom

$32.44

0.08 (0.25%)

14:25
09/24/18
09/24
14:25
09/24/18
14:25
Options
Viacom call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
09/24/18
09/24
14:25
09/24/18
14:25
General news
FOMC begins its 2-day meeting Tuesday, with the announcement due Wednesday at 14 ET »

FOMC begins its 2-day…

ESRX

Express Scripts

$94.41

-0.2 (-0.21%)

, GILD

Gilead

$75.68

0.17 (0.23%)

14:20
09/24/18
09/24
14:20
09/24/18
14:20
Hot Stocks
Express Scripts calls Gilead action 'step in the right direction' »

Express Scripts (ESRX)…

ESRX

Express Scripts

$94.41

-0.2 (-0.21%)

GILD

Gilead

$75.68

0.17 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/24/18
09/24
14:17
09/24/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.